T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Simpson Manufacturing
SSD
$8B
| $43.8M | 0.01% |
292,407
+208,122
| +247% | +$31.6M |
|
727
Cactus
WHD
$5.78B
| $43.7M | 0.01% |
870,598
-8,361
| -1% | -$420K |
|
728
CorVel
CRVL
$3.25B
| $43.6M | 0.01% |
665,790
-14,643
| -2% | -$1.01M |
|
729
APA Corp
APA
$14B
| $43.6M | 0.01% |
1,061,834
+131,415
| +14% | +$5.41M |
|
730
Diodes
DIOD
$4.48B
| $43.4M | 0.01% |
550,424
+627
| +0.1% | +$52.7K |
|
731
Roivant Sciences
ROIV
$26.2B
| $43.4M | 0.01% |
3,712,482
+3,662,354
| +7,306% | +$41.4M |
|
732
Paycom
PAYC
$10.1B
| $42.8M | 0.01% |
165,264
-597,825
| -78% | -$182M |
|
733
DoubleVerify
DV
$2.04B
| $42.8M | 0.01% |
1,532,189
+139,943
| +10% | +$4.78M |
|
734
On Holding
ONON
$10.6B
| $42.8M | 0.01% |
1,537,883
+1,528,424
| +16,158% | +$48.4M |
|
735
Power Integrations
POWI
$3.48B
| $42.8M | 0.01% |
560,505
-43,955
| -7% | -$3.76M |
|
736
Casey's General Stores
CASY
$31.6B
| $42.7M | 0.01% |
157,106
-6,291
| -4% | -$1.59M |
|
737
Alkermes
ALKS
$8.3B
| $42.6M | 0.01% |
1,520,485
+11,039
| +0.7% | +$324K |
|
738
VICI Properties
VICI
$29B
| $42.5M | 0.01% |
1,460,681
+1,446
| +0.1% | +$44.9K |
|
739
Ferguson
FERG
$48B
| $42.2M | 0.01% |
256,667
+2,947
| +1% | +$465K |
|
|
RNAM
740
DELISTED
Avidity Biosciences
RNAM
| $42.2M | 0.01% |
6,616,423
-67,818
| -1% | -$584K |
|
741
The Bancorp
TBBK
$2.82B
| $42M | 0.01% |
1,216,763
+112,180
| +10% | +$4.09M |
|
742
DraftKings
DKNG
$12.6B
| $41.5M | 0.01% |
1,411,175
+366,004
| +35% | +$10.8M |
|
743
Arm
ARM
$298B
| $41.2M | 0.01% |
+770,695
| New | +$42.6M |
|
744
W.W. Grainger
GWW
$62.2B
| $40.9M | 0.01% |
59,074
-877
| -1% | -$634K |
|
745
Workiva
WK
$4.01B
| $40.7M | 0.01% |
402,055
+6,927
| +2% | +$720K |
|
746
Blue Owl Capital
OWL
$19.7B
| $40.6M | 0.01% |
3,130,329
-178,565
| -5% | -$2.13M |
|
747
Keros Therapeutics
KROS
$211M
| $40.4M | 0.01% |
1,267,232
-3,129
| -0.2% | -$117K |
|
748
Littelfuse
LFUS
$11.4B
| $40.2M | 0.01% |
162,738
-478
| -0.3% | -$129K |
|
749
Agios Pharmaceuticals
AGIO
$2B
| $40.2M | 0.01% |
1,626,110
+332,718
| +26% | +$8.8M |
|
750
BJs Wholesale Club
BJ
$11.9B
| $40.1M | 0.01% |
562,155
-405,088
| -42% | -$27.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.